A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. [electronic resource]
Producer: 20140128Description: 533-43 p. digitalISSN:- 1760-4788
- Absorptiometry, Photon
- Aged
- Aged, 80 and over
- Azasteroids -- administration & dosage
- Body Composition -- drug effects
- Dietary Proteins -- administration & dosage
- Dietary Supplements
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Frail Elderly
- Humans
- Muscle Strength -- drug effects
- Muscle, Skeletal -- drug effects
- Musculoskeletal Physiological Phenomena -- drug effects
- Receptors, Androgen -- drug effects
- Sarcopenia -- drug therapy
- Vitamin D -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.